The coagulation factor VII in pregnancy

Summary. The hypercoagulable state in pregnancy is partly caused by the increased activity of factor VII in plasma. We demonstrate here that this activity is reduced to levels similar to those in plasma from non‐pregnant women by highly purified phospholipase C from Bacillus cereus, i.e. the activity increase is due to a circulating complex of factor VII and a phospholipase C‐sensitive compound. Phospholipase C had no effect on the levels of factor II and X in blood from pregnant women. This novel form of activated factor VII is not inhibited by an antiserum to the protein component of thromboplastin (apoprotein III). By gel filtration of plasma from pregnant women on Sephadex G‐100 the phospholipase C‐sensitive complex was partly separated from non‐phospholipase sensitive factor VII also present in the same plasma.

[1]  B. Østerud.  How to measure factor VII and factor VII activation. , 1983 .

[2]  B. Osterud.  How to measure factor VII and factor VII activation. , 1983, Haemostasis.

[3]  T. Lyberg,et al.  Synthesis of thromboplastin (factor III) in mouse placental cells in vitro. , 1983, Gynecologic and obstetric investigation.

[4]  H. Prydz,et al.  Phospholipase C from Bacillus cereus has sphingomyelinase activity. , 1982, Scandinavian journal of clinical and laboratory investigation.

[5]  J. Griffin,et al.  Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. , 1979, The Journal of clinical investigation.

[6]  B. Osterud,et al.  The interaction of human blood coagulation factor VII and tissue factor: the effect of anti factor VII, anti tissue factor and diisopropylfluorophosphate. , 1979, Biochemical and biophysical research communications.

[7]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Claeson,et al.  A new sensitive and highly specific chromogenic peptide substrate for factor Xa. , 1977, Thrombosis research.

[9]  E. Storm,et al.  Purification and some properties of the protein component of tissue thromboplastin from human brain. , 1977, The Biochemical journal.

[10]  C. Little,et al.  Purification by affinity chromatography of phospholipase C from Bacillus cereus , 1975, FEBS letters.

[11]  M. Fagerhol,et al.  Studies on Coagulation and Fibrinolysis in Pregnancy , 1975, Acta obstetricia et gynecologica Scandinavica.

[12]  B. Osterud,et al.  Activation of the coagulation factor VII by tissue thromboplastin and calcium. , 1972, Biochemistry.

[13]  H. Prydz,et al.  Phospholipase C from Bacillus cereus and its use in studies of tissue thromboplastin. , 1972, European journal of biochemistry.

[14]  H. Prydz,et al.  Studies on tissue thromboplastin: I. Solubilization with sodium deoxycholate , 1966 .

[15]  P. A. Nilsen.  The Mechanism of Hypofibrinogenæmia in Premature Separation of the Normally Implanted Placenta , 1963 .

[16]  B. Alexander.  Blood coagulation in pregnancy. , 1956, Transactions of the New England Obstetrical and Gynecological Society.

[17]  L. Meyers,et al.  Blood coagulation in pregnancy: proconvertin and prothrombin, and the hypercoagulable state. , 1956, The New England journal of medicine.

[18]  C. Schneider.  The active principle of placental toxin; thromboplastin; its inactivator in blood; antithromboplastin. , 1947, The American journal of physiology.